Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call Transcript - Thomson StreetEvents

Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call Transcript

Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call Transcript - Thomson StreetEvents
Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call Transcript
Published Sep 21, 2023
21 pages (14029 words) — Published Sep 21, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of TVTX.OQ conference call or presentation 21-Sep-23 12:30pm GMT

  
Brief Excerpt:

...Operator Good day, and welcome to the Travere Therapeutics Corporate Update Call. Today's conference call is being recorded. At this time, I would like to turn the conference call over to the Vice President of Investor Relations, Naomi Eichenbaum. Please go ahead, Naomi. Naomi Eichenbaum Thank you, Ruth, and thank you all for joining us today. Earlier today, we issued a press release announcing the confirmatory data from the Phase III PROTECT study of FILSPARI in IgA Nephropathy. A copy of the press release, along with the slides that we will be reviewing on today's call are available on the Investors section of our website. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube. Joining Eric will be our Chief Medical Officer, Dr. Jula Inrig and we are joined by guest speaker and key opinion leader, Dr. Brad Rovin, the Director of the Division of Nephrology at Ohio State University, Wexner Medical Center. Dr. Bill Rote, our Senior Vice President of Research and Development,...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Travere Therapeutics Inc
Ticker
TVTX.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Travere Therapeutics Inc Q4 2024 Earnings Call Transcript – 2025-02-20 – US$ 54.00 – Edited Transcript of TVTX.OQ earnings conference call or presentation 20-Feb-25 9:30pm GMT

Travere Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2025-01-14 – US$ 54.00 – Edited Transcript of TVTX.OQ presentation 14-Jan-25 4:15pm GMT

Travere Therapeutics Inc at Citi Global Healthcare Conference Transcript – 2024-12-04 – US$ 54.00 – Edited Transcript of TVTX.OQ presentation 4-Dec-24 7:30pm GMT

Travere Therapeutics Inc Q3 2024 Earnings Call Transcript – 2024-10-31 – US$ 54.00 – Edited Transcript of TVTX.OQ earnings conference call or presentation 31-Oct-24 12:30pm GMT

Travere Therapeutics Inc Q3 2023 Earnings Call Transcript – 2023-11-07 – US$ 54.00 – Edited Transcript of TVTX.OQ earnings conference call or presentation 7-Nov-23 9:30pm GMT

Travere Therapeutics Inc Q2 2023 Earnings Call Transcript – 2023-08-03 – US$ 54.00 – Edited Transcript of TVTX.OQ earnings conference call or presentation 3-Aug-23 8:30pm GMT

Travere Therapeutics Inc at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of TVTX.OQ presentation 7-Jun-23 3:00pm GMT

Travere Therapeutics Inc at William Blair Growth Stock Conference Transcript – 2023-06-06 – US$ 54.00 – Edited Transcript of TVTX.OQ presentation 6-Jun-23 5:40pm GMT

Travere Therapeutics Inc Pegtibatinase in Classical Homocystinuria Phase 1/2 COMPOSE Study Results Call Transcript – 2023-05-31 – US$ 54.00 – Edited Transcript of TVTX.OQ conference call or presentation 31-May-23 12:30pm GMT

Travere Therapeutics Inc at Bank of America Global Healthcare Conference Transcript – 2023-05-10 – US$ 54.00 – Edited Transcript of TVTX.OQ presentation 10-May-23 10:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call Transcript" Sep 21, 2023. Alacra Store. May 03, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Travere-Therapeutics-Inc-FILSPARI-in-IgA-Nephropathy-Phase-3-PROTECT-Study-Results-Call-T15753264>
  
APA:
Thomson StreetEvents. (2023). Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call Transcript Sep 21, 2023. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Travere-Therapeutics-Inc-FILSPARI-in-IgA-Nephropathy-Phase-3-PROTECT-Study-Results-Call-T15753264>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.